Bihua Chen

Insider Reports History

Location
C/O Cormorant Asset Management, Lp, 200 Clarendon Street, 52 Nd Floor, Boston, MA
Signature
/s/ Bihua Chen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bihua Chen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Oncology Therapeutics, Inc. Director, 10%+ Owner Common Stock 5.95M $63.8M $10.72 Aug 11, 2025 Via Master Fund
BridgeBio Oncology Therapeutics, Inc. Director, 10%+ Owner Common Stock 4.53M $48.5M $10.72 Aug 11, 2025 Via Helix Holdings II LLC
BridgeBio Oncology Therapeutics, Inc. Director, 10%+ Owner Common Stock 3.31M $35.4M $10.72 Aug 11, 2025 Via Fund V
BridgeBio Oncology Therapeutics, Inc. Director, 10%+ Owner Common Stock 2.19M $23.4M $10.72 Aug 11, 2025 Via Fund III
BridgeBio Oncology Therapeutics, Inc. Director, 10%+ Owner Common Stock 1.91M $20.4M $10.72 Aug 11, 2025 Via Fund IV
Erasca, Inc. Director Common Stock 10.8M $17.2M $1.59 Jun 22, 2023 Indirect
MoonLake Immunotherapeutics Former 10% Owner Class A Ordinary Shares 1.99M $13.9M $6.96 Sep 30, 2025 Indirect
Biomea Fusion, Inc. Former Director Common Stock 3.57M $5.82M $1.63 Aug 1, 2025 Indirect
Biomea Fusion, Inc. Former Director Stock Option (Right to Buy) 92K $150K $1.63 Aug 1, 2025 Direct
Erasca, Inc. Director Stock Option (right to buy) 60K Jun 22, 2023 Direct
BridgeBio Oncology Therapeutics, Inc. Director, 10%+ Owner Class B ordinary shares 0 Aug 11, 2025 Indirect

Insider Reports Filed by Bihua Chen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MLTX MoonLake Immunotherapeutics Sep 29, 2025 5 -$46.9M 4 Oct 1, 2025 Former 10% Owner
BBOT BridgeBio Oncology Therapeutics, Inc. Aug 11, 2025 10 $75M 4 Aug 13, 2025 Director, 10%+ Owner
BMEA Biomea Fusion, Inc. Aug 1, 2025 0 $0 4 Aug 1, 2025 Former Director
BMEA Biomea Fusion, Inc. Jun 11, 2025 1 $0 4 Jun 13, 2025 Director, 10%+ Owner
HLXB Helix Acquisition Corp. II Feb 8, 2025 1 $0 4 Feb 10, 2025 CEO and Chairperson, Director, 10%+ Owner
BMEA Biomea Fusion, Inc. Jun 12, 2024 1 $0 4 Jun 13, 2024 Director, 10%+ Owner
HLXB Helix Acquisition Corp. II Feb 13, 2024 4 $29.1M 4 Feb 13, 2024 CEO and Chairperson, Director, 10%+ Owner
HLXB Helix Acquisition Corp. II Feb 8, 2024 0 $0 3 Feb 9, 2024 CEO and Chairperson, Director, 10%+ Owner
MLTX MoonLake Immunotherapeutics Oct 5, 2023 1 $3.52M 4 Oct 10, 2023 10%+ Owner
MLTX MoonLake Immunotherapeutics Oct 2, 2023 3 $16.8M 4 Oct 4, 2023 10%+ Owner
MLTX MoonLake Immunotherapeutics Jun 30, 2023 1 $40M 4 Jul 5, 2023 10%+ Owner
MLTX MoonLake Immunotherapeutics Jun 26, 2023 27 $20.5M 4 Jun 28, 2023 10%+ Owner
ERAS Erasca, Inc. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
BMEA Biomea Fusion, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director, 10%+ Owner
BMEA Biomea Fusion, Inc. Mar 30, 2023 1 $12M 4 Apr 3, 2023 Director, 10%+ Owner
MLTX MoonLake Immunotherapeutics Mar 20, 2023 4 $16.8M 4 Mar 22, 2023 10%+ Owner
ERAS Erasca, Inc. Dec 20, 2022 1 $2M 4 Dec 20, 2022 Director
ERAS Erasca, Inc. Dec 13, 2022 1 $2M 4/A Dec 21, 2022 Director
ERAS Erasca, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
BMEA Biomea Fusion, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director, 10%+ Owner
MLTX MoonLake Immunotherapeutics Apr 5, 2022 3 $28.5M 4 Apr 7, 2022 10%+ Owner
ERAS Erasca, Inc. Jul 26, 2021 2 $667K 4 Aug 10, 2021 Director
ERAS Erasca, Inc. Jul 20, 2021 5 $15.2M 4 Jul 22, 2021 Director
ERAS Erasca, Inc. Jul 15, 2021 0 $0 3/A Jul 16, 2021 Director, 10%+ Owner